184 related articles for article (PubMed ID: 25499221)
1. KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells.
Taniuchi K; Furihata M; Saibara T
Neoplasia; 2014 Dec; 16(12):1082-93. PubMed ID: 25499221
[TBL] [Abstract][Full Text] [Related]
2. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer.
Taniuchi K; Furihata M; Hanazaki K; Saito M; Saibara T
Oncotarget; 2014 Aug; 5(16):6832-45. PubMed ID: 25216519
[TBL] [Abstract][Full Text] [Related]
3. ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancer.
Taniuchi K; Furihata M; Naganuma S; Saibara T
Int J Oncol; 2018 Nov; 53(5):2224-2240. PubMed ID: 30226582
[TBL] [Abstract][Full Text] [Related]
4. IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.
Ennajdaoui H; Howard JM; Sterne-Weiler T; Jahanbani F; Coyne DJ; Uren PJ; Dargyte M; Katzman S; Draper JM; Wallace A; Cazarez O; Burns SC; Qiao M; Hinck L; Smith AD; Toloue MM; Blencowe BJ; Penalva LO; Sanford JR
Cell Rep; 2016 May; 15(9):1876-83. PubMed ID: 27210763
[TBL] [Abstract][Full Text] [Related]
5. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
Lin CY; Chen ST; Jeng YM; Yeh CC; Chou HY; Deng YT; Chang CC; Kuo MY
J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
[TBL] [Abstract][Full Text] [Related]
7. CCDC88A, a prognostic factor for human pancreatic cancers, promotes the motility and invasiveness of pancreatic cancer cells.
Tanouchi A; Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Kimura M; Watanabe R; Kohsaki T; Shimizu T; Saito M; Hanazaki K; Saibara T
J Exp Clin Cancer Res; 2016 Dec; 35(1):190. PubMed ID: 27919290
[TBL] [Abstract][Full Text] [Related]
8. WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.
Taniuchi K; Furihata M; Naganuma S; Saibara T
Cancer Med; 2018 Nov; 7(11):5733-5751. PubMed ID: 30353690
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor HOXB7 regulates ERK kinase activity and thereby stimulates the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Shimizu T; Saito M; Saibara T
J Biol Chem; 2017 Oct; 292(43):17681-17702. PubMed ID: 28912272
[No Abstract] [Full Text] [Related]
10. RUVBL1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion.
Taniuchi K; Furihata M; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
Int J Oncol; 2014 Jun; 44(6):1945-54. PubMed ID: 24728183
[TBL] [Abstract][Full Text] [Related]
11. Vav3 is linked to poor prognosis of pancreatic cancers and promotes the motility and invasiveness of pancreatic cancer cells.
Tsuboi M; Taniuchi K; Furihata M; Naganuma S; Kimura M; Watanabe R; Shimizu T; Saito M; Dabanaka K; Hanazaki K; Saibara T
Pancreatology; 2016; 16(5):905-16. PubMed ID: 27453460
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.
Mizutani R; Imamachi N; Suzuki Y; Yoshida H; Tochigi N; Oonishi T; Suzuki Y; Akimitsu N
Oncogene; 2016 Jul; 35(27):3495-502. PubMed ID: 26522719
[TBL] [Abstract][Full Text] [Related]
13.
Panebianco F; Kelly LM; Liu P; Zhong S; Dacic S; Wang X; Singhi AD; Dhir R; Chiosea SI; Kuan SF; Bhargava R; Dabbs D; Trivedi S; Gandhi M; Diaz R; Wald AI; Carty SE; Ferris RL; Lee AV; Nikiforova MN; Nikiforov YE
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2307-2312. PubMed ID: 28193878
[TBL] [Abstract][Full Text] [Related]
14. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell.
Taniuchi K; Nakagawa H; Nakamura T; Eguchi H; Ohigashi H; Ishikawa O; Katagiri T; Nakamura Y
Cancer Res; 2005 Jan; 65(1):105-12. PubMed ID: 15665285
[TBL] [Abstract][Full Text] [Related]
17. α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation.
Uno M; Kokuryo T; Yokoyama Y; Senga T; Nagino M
Anticancer Res; 2016 Feb; 36(2):583-9. PubMed ID: 26851012
[TBL] [Abstract][Full Text] [Related]
18. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells.
Sekine H; Chen N; Sato K; Saiki Y; Yoshino Y; Umetsu Y; Jin G; Nagase H; Gu Z; Fukushige S; Sunamura M; Horii A
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):214-9. PubMed ID: 23085231
[TBL] [Abstract][Full Text] [Related]
19. Cold Shock Domain Containing E1 (CSDE1) Protein is Overexpressed and Can be Targeted to Inhibit Invasiveness in Pancreatic Cancer Cells.
Liu H; Li X; Dun MD; Faulkner S; Jiang CC; Hondermarck H
Proteomics; 2020 May; 20(10):e1900331. PubMed ID: 32170829
[TBL] [Abstract][Full Text] [Related]
20. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
